What's Bottle of Lies about?

The fight for drug quality remains unresolved. While Ranbaxy crumbled and whistleblowers like Dinesh Thakur spoke out, the FDA gradually softened its stance on inspections. Peter Baker's discoveries in China and India exposed widespread fraud, but regulatory compromises persisted. Even today, the same forces that prioritized profits over safety continue to shape our medicine supply, leaving patients to bear the invis...